Literature DB >> 16361667

Impaired expression of thrombospondin-1 in eyes with age related macular degeneration.

K Uno1, I A Bhutto, D S McLeod, C Merges, G A Lutty.   

Abstract

AIMS: This study investigated the expression and localisation of thrombospondin-1 (TSP-1), a known anti-angiogenic extracellular matrix protein, in normal aged control human eyes and eyes with age related macular degeneration (AMD).
METHODS: Immunohistochemical analysis with mouse anti-human TSP-1 antibody and mouse anti-human CD 34 antibody, as a blood vessel marker, was performed on frozen sections from macular and peripheral blocks of aged control donor eyes (n = 12; mean age 78.8 years), and eyes with AMD (n = 12; mean age 83.9 years). Pigment in retinal pigment epithelium (RPE) and choroidal melanocytes was bleached. Three independent observers scored the immunohistochemical reaction product.
RESULTS: In the macular region, TSP-1 expression was observed intensely in Bruch's membrane and weakly in RPE basement membrane, choriocapillaris, and the wall of large choroidal blood vessels in the aged control eyes. In eyes with AMD, TSP-1 immunoreactivity was significantly lower in all structures except RPE basement membrane (p<0.01). There was significantly lower TSP-1 in the far periphery than the equator and submacular regions in all eyes. TSP-1 immunoreactivity was low in choroidal neovascularisation (CNV), but it was high and diffuse in adjacent scar tissue.
CONCLUSION: These findings suggest that decreased TSP-1 in Bruch's membrane and choroidal vessels during AMD may permit the formation of CNV.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16361667      PMCID: PMC1856899          DOI: 10.1136/bjo.2005.074005

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  36 in total

1.  Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture.

Authors:  W R Green; C Enger
Journal:  Ophthalmology       Date:  1993-10       Impact factor: 12.079

2.  Ultrastructural localization of extracellular matrix components in human retinal vessels and Bruch's membrane.

Authors:  A Das; R N Frank; N L Zhang; T J Turczyn
Journal:  Arch Ophthalmol       Date:  1990-03

3.  Thrombospondin-1, a natural inhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia.

Authors:  N Sheibani; C M Sorenson; L A Cornelius; W A Frazier
Journal:  Biochem Biophys Res Commun       Date:  2000-01-07       Impact factor: 3.575

4.  Pathologic features of senile macular degeneration.

Authors:  W R Green; P J McDonnell; J H Yeo
Journal:  Ophthalmology       Date:  1985-05       Impact factor: 12.079

5.  The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; S C Jensen; S M Meuer
Journal:  Ophthalmology       Date:  1997-01       Impact factor: 12.079

6.  Heterogeneity in localization of isoforms of TGF-beta in human retina, vitreous, and choroid.

Authors:  G A Lutty; C Merges; A B Threlkeld; S Crone; D S McLeod
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-03       Impact factor: 4.799

7.  Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid.

Authors:  D S McLeod; D J Lefer; C Merges; G A Lutty
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

8.  Expression of thrombospondins by endothelial cells. Injury is correlated with TSP-1.

Authors:  M J Reed; L Iruela-Arispe; E R O'Brien; T Truong; T LaBell; P Bornstein; E H Sage
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

9.  Thrombospondin: a component of microfibrils in various tissues.

Authors:  B B Arbeille; F M Fauvel-Lafeve; M B Lemesle; D Tenza; Y J Legrand
Journal:  J Histochem Cytochem       Date:  1991-10       Impact factor: 2.479

10.  Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity.

Authors:  S S Tolsma; O V Volpert; D J Good; W A Frazier; P J Polverini; N Bouck
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539

View more
  27 in total

1.  Reduction of endogenous angiogenesis inhibitors in Bruch's membrane of the submacular region in eyes with age-related macular degeneration.

Authors:  Imran A Bhutto; Koichi Uno; Carol Merges; Lei Zhang; D Scott McLeod; Gerard A Lutty
Journal:  Arch Ophthalmol       Date:  2008-05

2.  Thrombospondin-1-Based Antiangiogenic Therapy.

Authors:  Jennifer N Sims; Jack Lawler
Journal:  J Ocul Pharmacol Ther       Date:  2015-06-03       Impact factor: 2.671

3.  Lack of thrombospondin 1 and exacerbation of choroidal neovascularization.

Authors:  Shoujian Wang; Christine M Sorenson; Nader Sheibani
Journal:  Arch Ophthalmol       Date:  2012-05

4.  Bruch's Membrane and the Choroid in Age-Related Macular Degeneration.

Authors:  Malia Edwards; Gerard A Lutty
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation.

Authors:  Sharmila Masli; Nader Sheibani; Claus Cursiefen; James Zieske
Journal:  Curr Eye Res       Date:  2014-02-21       Impact factor: 2.424

6.  The potential of nanomedicine therapies to treat neovascular disease in the retina.

Authors:  Krysten M Farjo; Jian-Xing Ma
Journal:  J Angiogenes Res       Date:  2010-10-08

7.  PEDF-deficient mice exhibit an enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel obliteration.

Authors:  Qiong Huang; Shoujian Wang; Christine M Sorenson; Nader Sheibani
Journal:  Exp Eye Res       Date:  2008-06-17       Impact factor: 3.467

Review 8.  Thrombospondin-1: a physiological regulator of nitric oxide signaling.

Authors:  J S Isenberg; W A Frazier; D D Roberts
Journal:  Cell Mol Life Sci       Date:  2008-03       Impact factor: 9.261

9.  Modulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetes.

Authors:  Shoujian Wang; Justin L Gottlieb; Christine M Sorenson; Nader Sheibani
Journal:  Arch Ophthalmol       Date:  2009-04

Review 10.  Microvascular complications and diabetic retinopathy: recent advances and future implications.

Authors:  Megha Barot; Mitan R Gokulgandhi; Sulabh Patel; Ashim K Mitra
Journal:  Future Med Chem       Date:  2013-03       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.